Krebs Biochemicals & Industries Ltd.
| BSE: 524518 | Sector: Health care |
| NSE: KREBSBIO | ISIN Code: INE268B01013 |
| BSE 00:00 | 03 Feb | 96.30 |
-3.10 (-3.12%) |
OPEN
101.10 |
HIGH
101.10 |
LOW
94.10 |
| NSE 00:00 | 03 Feb | 95.20 |
-3.60 (-3.64%) |
OPEN
98.15 |
HIGH
101.50 |
LOW
93.60 |
| OPEN | 101.10 |
| PREVIOUS CLOSE | 99.40 |
| VOLUME | 1881 |
| 52-Week high | 190.00 |
| 52-Week low | 94.10 |
| P/E | |
| Mkt Cap.(Rs cr) | 208 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Krebs Biochemicals & Industries Ltd. (KREBSBIO) - Announcements
-
Krebs Biochemicals & Industries Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
04/02/2023 | bse |
Downlaod PDF -
Krebs Biochemicals & Industries Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
04/02/2023 | bse |
Downlaod PDF -
Krebs Biochemicals & Industries Ltd Appointment Of CFO Announcement Of Regulation 30
03/02/2023 | bse |
Downlaod PDF -
Krebs Biochemicals & Industries Ltd Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
03/02/2023 | bse |
Downlaod PDF -
Krebs Biochemicals & Industries Ltd Un-Audited Financial Results For Quarter Ended 31.12.2022 With Digital Signature
03/02/2023 | bse |
Downlaod PDF -
Krebs Biochemicals & Industries Ltd Board Meeting Outcome for Revised Outcome With Digital Signature
03/02/2023 | bse |
Downlaod PDF -
Krebs Biochemicals & Industries Ltd Appointment of Company Secretary and Compliance Officer
03/02/2023 | bse |
Downlaod PDF -
Krebs Biochemicals & Industries Ltd Appointment Of CFO Announcement Under Regulation 30
03/02/2023 | bse |
Downlaod PDF -
Krebs Biochemicals & Industries Ltd Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
03/02/2023 | bse |
Downlaod PDF -
Krebs Biochemicals & Industries Ltd Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2022
03/02/2023 | bse |
Downlaod PDF -
Krebs Biochemicals & Industries Ltd Appointment of Company Secretary and Compliance Officer
03/02/2023 | bse |
Downlaod PDF -
Krebs Biochemicals & Industries Ltd Board Meeting Outcome for Outcome Of The Board Meeting
03/02/2023 | bse |
Downlaod PDF -
Krebs Biochemicals & Industries Ltd Board Meeting Intimation for Unaudited Financial Results For The 3Rd Quarter And Nine Months Ended D
23/01/2023 | bse |
Downlaod PDF -
Krebs Biochemicals & Industries Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
11/01/2023 | bse |
Downlaod PDF -
Krebs Biochemicals & Industries Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
03/01/2023 | bse |
Downlaod PDF -
Krebs Biochemicals & Industries Ltd Closure of Trading Window
26/12/2022 | bse |
Downlaod PDF -
Krebs Biochemicals & Industries Ltd Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange
24/11/2022 | bse |
Downlaod PDF -
Krebs Biochemicals & Industries Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
14/11/2022 | bse |
Downlaod PDF -
Krebs Biochemicals & Industries Ltd Q2fy23 Results
10/11/2022 | bse |
Downlaod PDF -
Krebs Biochemicals & Industries Ltd Board Meeting Outcome for Q2FY23 Results
10/11/2022 | bse |
Downlaod PDF
Quick Links for Krebs Biochemicals & Industries:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
